Bill117th CongressFiled May 26, 2022Health
S. 4340
EFFECTIVE Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in senate (May 26, 2022)
Ensuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement Act or the EFFECTIVE Act
This bill specifies that the Food and Drug Administration may deny an application for a new opioid analgesic drug upon a determination that the drug does not provide a significant advantage or clinical superiority compared to other drugs.
What just happenedMay 26, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Who’s behind it
Sen. Manchin, Joe, III [D-WV](D-WV)Sponsor
1 cosponsor1 R
1cosponsors1committees2actions1related bills
- Introduced in SenateMay 26, 2022
- May 26, 2022IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health, Education, Labor, and Pensions Committee - May 26, 2022IntroReferral10000
Introduced in Senate